Showing 2921-2930 of 3223 results for "".
- CMS Provides Regulatory Relief on Staffing, Paperwork as COVID-19 Cases Surgehttps://modernod.com/news/cms-provides-regulatory-relief-on-staffing-paperwork-as-covid-19-cases-surge/2477504/The Trump administration released a raft of regulatory changes intended to bolster hospitals including setting up alternative sites of care and methods to rapidly boost healthcare workers, according to a FierceHealthcare
- Ophthalmologists Share Their Strategies for Managing Stresshttps://modernod.com/news/ophthalmologists-share-their-strategies-for-managing-stress/2477502/As COVID-19 spreads across the globe, an increasing number of ophthalmologists are canceling routine appointments and elective surgeries and transitioning to providing only urgent care. Many eye care providers are doing their best to keep their practices afloat, support their staff, care for thei
- ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Updatehttps://modernod.com/news/proqr-announces-positive-findings-from-an-interim-analysis-in-the-phase-1-2-trial-of-qr-421a-for-usher-syndrome-and-provides-business-update/2477500/ProQR Therapeutics announced positive findings from a planned 3-month interim analysis of its Phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa (nsRP) due to USH2A exon 13 mutations. The company is also providing an update
- OOTG Webcast: Weathering the Storm and Supporting Staffhttps://modernod.com/news/ootg-webcast-weathering-the-storm-and-supporting-staff/2477488/“Ophthalmology off the Grid” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, sat down—virtually—with Robert Weinstock, MD, and Elizabeth Yeu, MD, on March 27 to discuss how the COVID-19 crisis is
- US Department of Labor Provides Guidance on Paid Sick and Family Leavehttps://modernod.com/news/us-department-of-labor-provides-guidance-on-paid-sick-and-family-leave/2477487/The Department of Labor just updated its ‘Questions and Answers’ on paid sick and family leave during the COVID-19 pandemic. This includes guidance on: (i) teleworking, furloughs, layoffs, reduced schedules, and office closures (employees are not eligible for paid sick o
- Eyevance Pharmaceuticals Launches Zerviate in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-launches-zerviate-in-the-united-states/2477486/Eyevance Pharmaceuticals has announced the United States launch of Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis. Zerviate is formulated with Hydrella, the vehicle that contains glycerin and hydroxypropyl methylcellulos
- Live Webcast: COVID-19 Impact on Retina Practiceshttps://modernod.com/news/live-webcast-covid-19-impact-on-retina-practices/2477468/Bryn Mawr Communications (BMC) will host a live video webcast of its New Retina Radio podcast on Friday at 12 pm ET. The webcast, “How Retina Doctors Are Altering Their Treatments During the COVID-19 Crisis, and How They Can Anticipate What’s Next,” will be hosted by John W. Kitchens, MD. Panelis
- FDA Grants Gilead Request to Drop Orphan Drug Designation for Potential COVID-19 Treatment Remdesivirhttps://modernod.com/news/fda-grants-gilead-request-to-drop-orphan-drug-designation-for-potential-covid-19-treatment-remdesivir/2477465/The FDA on Wednesday withdrew an orphan drug designation it had granted Gilead Sciences a few days ago for its investigational antiviral remdesivir to treat COVID-19. The company, which had made the request, said it will waive all benefits that come with the designation, including an
- Regeneron to Extend Payment Terms for Eylea (Aflibercept) Injectionhttps://modernod.com/news/regeneron-to-extend-payment-terms-for-eylea-aflibercept-injection/2477463/In response to the COVID-19 pandemic, Regeneron will temporarily extend physician payment terms for Eylea (aflibercept) purchases from authorized distributors to 150 days. This has no impact on current Eylea return policies. Physicians may be temporarily eligible for paymen
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p